OncoSec Medical (LTS:0KC7) OCF Yield %: 0.00 (As of Jul. 07, 2026)


LTS:0KC7 OncoSec Medical Inc LTS:0KC7
40 GF Score
Price $143.00
View Full Analysis

What is OncoSec Medical OCF Yield %?

OncoSec Medical LTS:0KC7 40 OCF Yield % is 0.00 as of Jul. 07, 2026. GuruFocus rates LTS:0KC7 with a GF Score™ of 40/100.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, OncoSec Medical's Trailing 12-Month Cash Flow from Operations is $-25.00 Mil, and Market Cap is $0.00 Mil. Therefore, OncoSec Medical's OCF Yield % for today is 0.00%.

The historical rank and industry rank for OncoSec Medical's OCF Yield % or its related term are showing as below:


LTS:0KC7's OCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -7.99
* Ranked among companies with meaningful OCF Yield % only.

OncoSec Medical's OCF Margin % for the quarter that ended in Jan. 2023 was %.

OncoSec Medical OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

OncoSec Medical OCF Yield % Related Terms

OncoSec Medical OCF Yield % Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical OCF Yield % Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.32 -41.99 -22.12 -16.42 -12.56

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.66 -8.35 -10.81 -9.57 -6.22
LTS:0KC7
40GF Score
OncoSec Medical Inc LTS:0KC7
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OncoSec Medical OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

OncoSec Medical's OCF Yield % for the fiscal year that ended in Jul. 2022 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-32.138 / 255.96999821
=-12.56%

OncoSec Medical's annualized OCF Yield % for the quarter that ended in Jan. 2023 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-6.611 * 4 / 424.853
=-6.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
OncoSec Medical (LTS:0KC7) has a OCF Yield % of 0.00 as of Jul. 07, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's OCF Yield % too high?
OncoSec Medical's current OCF Yield % is 0.00. Overall, OncoSec Medical has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does OncoSec Medical's OCF Yield % compare to NOVNQ and USRM?
OncoSec Medical's OCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (LTS:0KC7) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. OncoSec Medical's overall GF Score™ is 40/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For OncoSec Medical (LTS:0KC7), the current OCF Yield % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.
40GF Score

Get the complete analysis for LTS:0KC7

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$143.00
Price